Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells

European Respiratory Journal

Volumn 39, Issue 2, 2012, Pages 446-457

  Spitalieri, P ^a   Quitadamo, M C ^a   Orlandi, A ^a   Guerra, L ^b   Giardina, E ^a   Casavola, V ^b   Novelli, G ^a   Saltini, C ^a   Sangiuolo, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Cell therapy; Human embryonic stem cells; Lung fibrosis; Silica damage

Indexed keywords

CELL NUCLEUS ANTIGEN; CHLORIDE ION; DNA; PROTEIN ZO1; SILICON DIOXIDE; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CHLORIDE TRANSPORT; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENGRAFTMENT; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROSIS; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SILICOSIS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TIGHT JUNCTION;

ANIMALS; CELL DIFFERENTIATION; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; FEEDER CELLS; FEMALE; FIBROBLASTS; HUMANS; MICE; MICE, NUDE; PULMONARY ALVEOLI; PULMONARY FIBROSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; SILICON DIOXIDE; SILICOSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84856712649     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00005511     Document Type: Article

References (53)

1. Mason RJ. Biology of alveolar type II cells. Respirology 2006; 11: Suppl., S12-S15.
2. Kajstura J, Rota M, Hall SR, et al. Evidence for human lung stem cells. N Engl J Med 2011; 364: 1795-1806.
3. Bishop AE. Pulmonary epithelial stem cells. Cell Prolif 2004; 37: 89-96. (Pubitemid 38250587)
4. Samadikuchaksaraei A, Cohen S, Isaac K, et al. Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng 2006; 12: 867-875. (Pubitemid 43726528)
5. Greenberg MI, Waksman J, Curtis J. Silicosis: a review. Dis Mon 2007; 53: 394-416. (Pubitemid 47633553)
6. Hunninghake GW, Kalica AR. Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 915-918.
7. Hamilton RF Jr, Thakur SA, Holian A. Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med 2008; 1, 44: 1246-1258.
8. Cowan CA, Klimanskaya I, McMahon J, et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 2004; 350: 1353-1356. (Pubitemid 38375373)
9. Isakson BE, Lubman RL, Seedorf GJ, et al. Modulation of pulmonary alveolar type II cell phenotype and communication by extracellular matrix and KGF. Am J Physiol Cell Physiol 2001; 281: C1291-C1299.
10. Fuchs S, Hollins AJ, Laue M, et al. Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C. Cell Tissue Res 2003; 311: 31-45. (Pubitemid 35478222)
11. Favia M, Guerra L, Fanelli T, et al. Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells. Mol Biol Cell 2010; 21: 73-86.
12. Spitalieri P, Cortese G, Pietropolli A. Identification of multipotent cytotrophoblast cells from human first trimester chorionic villi. Cloning Stem Cells 2009; 11: 535-556.
13. Guerra L, Fanelli T, Favia M, et al. Na+/H+ exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o- cells and rescues DeltaF508 CFTR functional expression in cystic fibrosis cells. J Biol Chem 2005; 280: 40925-40933. (Pubitemid 41780586)
14. Taddei A, Folli C, Zegarra-Moran O, et al. Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett 2004; 558: 52-56. (Pubitemid 38167409)
15. Green RL, Roinestead IC, Boland C, et al. Developmental validation of the Quantifiler™ real-time PCR kits for the quantification of human nuclear DNA samples. J Forensic Sci 2005; 50: 809-825. (Pubitemid 40917796)
16. Soncini M, Signoroni PB, Bailo M, et al. Use of highly sensitive mitochondrial probes to detect microchimerism in xenotransplantation models. Xenotransplantation 2006; 13: 80-85.
17. Hsia CC, Hyde DM, Ochs M, et al. ATS/ERS Joint Task Force on Quantitative Assessment of Lung Structure. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 2010; 181: 394-418.
18. Ashcroft T, Simpson JM, Timbrell V, et al. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41: 467-470. (Pubitemid 18098428)
19. Moodley YD, Atienza U, Manuelpillai CS, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009; 175: 303-313.
20. Yue X, Li X, Nguyen HT, et al. Transforming growth factor-β1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J Biol Chem 2008; 283: 20397-20407.
21. Gomperts BN, Belperio JA, Rao PN, et al. Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J Immunol 2006; 176: 1916-1927. (Pubitemid 43134337)
22. Bossard F, Robay A, Toumaniantz G, et al. NHE-RF1 protein rescues ΔF508-CFTR function. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1085-L1094. (Pubitemid 47084853)
23. Callis AH, Sohnle PG, Mandel GS, et al. Kinetics of inflammatory and fibrotic pulmonary changes in a murine model of silicosis. J Lab Clin Med 1985; 105: 547-553. (Pubitemid 15003234)
24. du Bois RM. Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov 2010; 9: 129-140.
25. Hay J, Shahzeidi S, Laurent G. Mechanisms of bleomycin induced lung damage. Arch Toxicol 1991; 65: 81-94.
26. Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100: 8407-8411. (Pubitemid 36842558)
27. Moodley Y, Ilancheran S, Samuel C, et al. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am J Respir Crit Care Med 2010; 182: 643-651.
28. Wang D, Morales JE, Calame DG, et al. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 2010; 18: 625-634.
29. Cargnoni AL, Gibelli A, Tosini PB, et al. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 2009; 18: 405-422.
30. Yildirim AO, Muyal V, John G, et al. Palifermin induces alveolar maintenance programs in emphysematous mice. Am J Respir Crit Care Med 2010; 181: 705-717.
31. Aguilar S, Scotton CJ, McNulty K, et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 2009; 4: e8013.
32. Gazdhar A, Fachinger P, van Leer C, et al. Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007; 292: L529-L536.
33. Sueblinvong VR, Loi PL, Eisenhauer I, et al. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Crit Care Med 2008; 177: 701-711.
34. Carraro GL, Perin S, Sedrakyan S, et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 2008; 26: 2902-2911.
35. Maron-Gutierrez T, Castiglione RC, Xisto DG, et al. Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis. Eur Respir J 2011; 37: 1217-1225.
36. Lassance RM, Prota LF, Maron-Gutierrez T, et al. Intratracheal instillation of bone marrow-derived cell in an experimental model of silicosis. Respir Physiol Neurobiol 2009; 169: 227-233.
37. Baritussio A, Bellina L, Carraro R, et al. Heterogeneity of alveolar surfactant in the rabbit: composition, morphology, and labelling of subfractions isolated by centrifugation of lung lavage. Eur J Clin Invest 1984; 14: 24-29. (Pubitemid 14190119)
38. Fang X, Song Y, Hirsch J. Contribution of CFTR to apical-basolateral fluid transport in cultured human alveolar epithelial type II cells. Am J Physiol Lung Cell Mol Physiol 2006; 290: L242-L249.
39. Melloni B, Lesur O, Bouhadiba T, et al. Effect of exposure to silica on human alveolar macrophages in supporting growth activity in type II epithelial cells. Thorax 1996; 51: 781-786. (Pubitemid 26274077)
40. Haase MG, Klawitter A, Bierhaus A, et al. Inactivation of AP1 proteins by a nuclear serine protease precedes the onset of radiation-induced fibrosing alveolitis. Radiat Res 2008; 169: 531-542. (Pubitemid 351671519)
41. Davis GS. The pathogenesis of silicosis: state of the art. Chest 1986; 89: 166S-169S. (Pubitemid 16105341)
42. Olszewski MA, Huffnagle GB, McDonald RA, et al. The role of macrophage in inflammatory protein-1α/CCL3 in regulation of T-cell-mediated immunity to Cryptococcus neoformans infection. J Immunol 2000; 165: 6429-6436.
43. Li XY, Donaldson K, Brown D, et al. The role of tumour necrosis factor in increased airspace epithelial permeability. Am J Respir Cell Mol Biol 1995; 13: 185-195.
44. Gosset P, Lassalle P, Vanhée D, et al. Production of tumour necrosis factor-α and interleukin-6 by human alveolar macrophages exposed in vitro to coal mine dust. Am J Respir Cell Mol Biol 1991; 5: 431-436.
45. Driscoll KE, Carter JM, Howard BW, et al. Crocidolite activates NF-κB and MIP-2 gene expression in rat alveolar epithelial cells. Role of mitochondrial-derived oxidants. Environ Health Perspect 1998; 106: Suppl. 5, 1171-1174. (Pubitemid 28554523)
46. Smith RE, Strieter RM, Phan SH, et al. TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury. J Leukoc Biol 1998; 64: 528-536. (Pubitemid 28455399)
47. Cutroneo KR. TGF-β-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen 2007; 15: Suppl. 1, S54-S60. (Pubitemid 47301675)
48. Driscoll B, Buckley S, Bui KC, et al. Telomerase in alveolar epithelial development and repair. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1191-L1198. (Pubitemid 32009505)
49. Schuyler MR, Gaumer HR, Stankus RP, et al. Bronchoalveolar lavage in silicosis. Evidence of type I cell hyperplasia. Lung 1980; 157: 95-102. (Pubitemid 10129751)
50. Sisson TH, Mendez M, Choi K, et al. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med 2010; 181: 254-263.
51. Chilosi M, Doglioni C, Murer B, et al. Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27: 7-18.
52. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev 2000; 177: 175-184.
53. Zhao F, Zhang YF, Liu YG, et al. Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc 2008; 40: 1700-1705. (Pubitemid 351853229)